先前使用氟嘧啶治疗的转移性结直肠癌的全身治疗的不良事件成本 ,美国以奥沙利铂和伊立替康为基础的化疗和生物制剂。
关键词: Medicare adverse events colorectal cancer costs formulary decision-making health economics healthcare resource use pharmacoeconomics
Mesh : Humans Colorectal Neoplasms / drug therapy economics United States Pyridines / economics therapeutic use adverse effects Thymine / therapeutic use Trifluridine / therapeutic use economics Antineoplastic Combined Chemotherapy Protocols / economics therapeutic use adverse effects Bevacizumab / economics therapeutic use adverse effects Phenylurea Compounds / therapeutic use economics adverse effects Benzofurans / economics therapeutic use adverse effects Irinotecan / therapeutic use economics Drug Combinations Pyrrolidines / therapeutic use economics Oxaliplatin / economics therapeutic use adverse effects Medicare / economics Camptothecin / analogs & derivatives therapeutic use economics adverse effects Quinazolines / economics therapeutic use adverse effects Organoplatinum Compounds / economics therapeutic use adverse effects Uracil / analogs & derivatives therapeutic use economics adverse effects Fluorouracil / therapeutic use economics adverse effects Models, Economic Biological Products / economics therapeutic use adverse effects
来 源:
DOI:10.57264/cer-2024-0084
PDF(Pubmed)